Subscribe

LSPN Fall North America 2024

LSPN Fall 2024 took place on October 15-16 in San Francisco, gathering an unrivalled assembly of in-house patent counsel, intellectual property professionals, and industry leaders from pharmaceutical and biotechnology companies. The event offered a unique opportunity to explore critical developments in the life sciences sector and provided attendees with actionable insights into patent strategies, key legal decisions, and the broader political landscape impacting innovation.

Speakers represented some of the biggest names in life sciences and intellectual property, including Acuitas Therapeutics, Thermo Fisher Scientific, 10x Genomics, Gilead Sciences, Pfizer, Bristol Myers Squibb, Illumina, Mammoth Biosciences, IGM Biosciences, DLA Piper, Morgan Lewis, Mintz, Nutcracker Therapeutics, and many more.

WATCH: International harmonization and global patent strategies
Join us as we delve into the complexities of international harmonization and global patent strategies in the ever-evolving landscape of IP rights.


WATCH: Beyond Patents-The evolving role of IP lawyers in life sciences
25 December 2024
WATCH: The new EU Clinical Trials Regulation – IP Considerations
25 December 2024
WATCH: What we have learned so far and other thoughts on the new European patent litigation system
24 December 2024
WATCH: The Unified Patent Court from the Frontline
24 December 2024
WATCH: European IP landscape
22 December 2024
WATCH: Jurisdictional overreach of foreign courts in patent disputes
22 December 2024


Americas
WATCH: Revolutionizing healthcare - medtech’s impact on patent strategy
The integration of cutting-edge medical technology within the life sciences has ushered in an era of unprecedented innovation, transforming the landscape of healthcare and patient wellbeing.
Americas
WATCH: Intersectionality of Intellectual Property with Licensing and Commercialization
In today's global marketplace, intellectual property (IP) rights are not merely legal tools but strategic assets that can significantly influence a product's lifecycle, from development to market.
Americas
WATCH: Bridging academia and industry - how can universities and industry work most effectively together?
How to foster effective collaboration between academia and industry? Best practices for bridging that gap between the two spheres Technology transfer How to leverage academic research for commercialization
Americas
WATCH: AI and machine learning in drug discovery - patenting AI-generated inventions
Machine learning can be an invaluable tool in drug discovery for target identification, compound screening, and predictive modeling. The use of AI can accelerate drug discovery timelines, reduce costs and enhance therapeutic outcomes.
Americas
WATCH: What are the latest challenges in patenting biologics, biosimilars, and bispecific antibodies?
The patent landscape for biologics, biosimilars, and advanced therapeutic antibodies is undergoing rapid change, presenting both opportunities and challenges for innovators and manufacturers. This panel will explore current issues and strategies in this dynamic field.
Americas
WATCH: Beyond the obvious: novelty, non-obviousness, and the inventive step in polymorph patents and beyond
In the world of intellectual property, securing patents for innovative ideas rests heavily on the criteria of novelty, non-obviousness, and the inventive step.
Americas
WATCH: The challenge of protecting patents and innovation - obviousness-type double patenting post In re Cellect
Obviousness-type double patenting can pose a significant challenge, as it can lead to unfair extensions of patent rights, and limit other’s abilities to build upon inventions, hindering further innovation.
Americas
WATCH: European patent term extension (SPCs)
European Supplementary Protection Certificates (SPCs) are very different to US PTEs in several key respects. In this seminar, we'll run through strategies to secure maximal protection for approved pharmaceutical & biologic products in Europe.



WATCH: Korean Biopharma's Global Expansion - Evolving Patent Strategies and Regulatory Landscape
4 December 2024   Korean pharmaceutical, biotech, and life sciences companies are actively expanding globally, leading to more complex and multifaceted IP strategies than in the past.
WATCH: Navigating the PTAB frontier - shaping patent strategies for success
2 December 2024   The dynamic landscape of patent law is continually influenced by evolving regulations and legal decisions, and one of the key areas at the forefront of these changes is the Patent Trial and Appeal Board (PTAB).
WATCH: Strategies for success: patent drafting and application
23 November 2024   Join us for a master class in patent drafting for successful applications to the USPTO. Our panel of experts will share invaluable insights into their best practices for success in patent drafting and application.
WATCH: Essential considerations: patenting and clinical trials
23 November 2024   There is an intricate intersection between patenting and clinical trials within the dynamic IP landscape in the life sciences industries. Safeguarding your innovation throughout the research process is critical, necessitating a careful balance between the need to file and when to file, explain speakers from IGM Biosciences, IP Recor Medical, and Sanaria Inc.
WATCH: How could AI patentability in Europe inform risk management discussions for investment in digital technology innovation within pharma?
14 November 2024   Patents are key to ensuring continued investment in pharma R&D. What are the unique patent considerations for pharma/biotech patents and AI patents in Europe?
WATCH: Navigating enablement and written description requirement standards in the USPTO
5 November 2024   On January 10 this year, the director of the USPTO issued new guidelines on enablement under 35 U.S.C §112. In recent years, the landscape of patent law in the United States has undergone a significant shift, with courts adopting a more stringent stance on the criteria of enablement and written description.
WATCH: Aligning innovation, regulation and IP protection
29 October 2024   Innovation in the life sciences industries is deeply intertwined with regulatory compliance and intellectual property protection. There is a complex interplay between IP and regulatory laws, creating unique challenges for lawyers working in this field. Join us as the panel discusses the delicate balance between innovation, regulatory requirements and safeguarding IP.